Search results for "Anticoagulation"
Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk
The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
https://immattersacp.org/weekly/archives/2016/11/15/6.htm
15 Nov 2016
Prescription NSAIDs associated with heart failure risk, study finds
A 19% increased risk for hospital admission for heart failure was found to be associated with any use of NSAIDs in the preceding 14 days versus past use of any NSAIDs. Diclofenac, ibuprofen, indomethacin, ketorolac, naproxen, nimesulide, piroxicam, etoricoxib, and rofecoxib were associated with increased risk for hospital admission.
https://immattersacp.org/weekly/archives/2016/10/04/1.htm
4 Oct 2016
Pharma payments to physicians associated with higher prescribing of 2 drug classes
Researchers calculated that 1 additional payment, of a median value of $13, was associated with 94 additional days of oral anticoagulant prescriptions and 107 days of noninsulin diabetes drugs in the hospital referral region where it was made.
https://immattersacp.org/weekly/archives/2016/08/23/5.htm
23 Aug 2016
CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care
A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016
Vitamin K antagonist use associated with higher risk of thrombosis than bleeding in patients ages 80 and older
Compared with patients ages 70 to 79 years, those ages 80 to 89 years had a similar risk of bleeding, whereas patients ages 90 years or older had a mildly increased risk of bleeding, the study found. Patients in their 80s and 90s had a markedly higher risk of thrombosis than did patients in their 70s.
https://immattersacp.org/weekly/archives/2016/07/12/4.htm
12 Jul 2016
ACC, AHA release updated performance, quality measures for afib
There are 24 total measures, including 6 performance measures (3 inpatient and 3 outpatient) and 18 quality measures (10 inpatient and 8 outpatient), all designed to assess care quality for inpatients and outpatients with atrial fibrillation and atrial flutter.
https://immattersacp.org/weekly/archives/2016/06/28/2.htm
28 Jun 2016
Atrial fibrillation patients often prescribed aspirin instead of anticoagulants, study finds
Cardiologists may be prescribing aspirin instead of oral anticoagulants because they think that aspirin is as efficacious as oral anticoagulants, or because they want to avoid the inconvenience of oral anticoagulation.
https://immattersacp.org/weekly/archives/2016/06/21/4.htm
21 Jun 2016
Optimizing medical therapy after stroke
Stroke survivors often leave the hospital with new prescriptions and substantial confusion about how, or even whether, to take them. This leaves internists with the sometimes formidable job of evaluating, prescribing, or tweaking these regimens, identifying and managing adverse effects, and reinforcing education about treatment risks, benefits, and adherence.
https://immattersacp.org/archives/2016/06/stroke.htm
1 Jun 2016
Oral anticoagulants for stroke prevention may be underprescribed in outpatients with AF
Specialists were more likely to prescribe an oral anticoagulant as the number of stroke risk factors increased as measured by the CHADS2 and CHA2DS2-VASc scores, the study noted.
https://immattersacp.org/weekly/archives/2016/03/22/2.htm
22 Mar 2016
MKSAP Quiz: evaluation for anticoagulation management
A 32-year-old woman is evaluated for anticoagulation management after an uncomplicated vaginal delivery of a healthy newborn. She was diagnosed with a bilateral pulmonary embolism at 25 weeks' gestation and was treated with therapeutic low-molecular-weight heparin (LMWH). The LMWH was discontinued at the onset of labor and was restarted 6 hours after delivery. Medical history is otherwise unremarkable, and her only medication is full-dose LMWH. Anticoagulation for 3 months is planned. The patient wishes to breastfeed her newborn. What is the most appropriate anticoagulation option for this patient?
https://immattersacp.org/weekly/archives/2016/02/23/3.htm
23 Feb 2016